A selective MAOB inhibitor Ro19-6327 potentiates the effects of levodopa on parkinsonism induced by MPTP in the common marmoset

Costa, 1972 Da Prada, 1990, From moclobemide to Ro19-6327 and Ro41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors, J. Neural Transm., 29, 179 Di Chiara, 1990, In vitro brain dialysis of neurotransmitters, Trends Pharmac. Sci., 11, 116, 10.1016/0165-6147(90)90197-G Glover, 1977, Dopamine is a monoamine oxidase B substrate in man, Nature, 265, 80, 10.1038/265080a0 May, 1991, [3H]Harman binding experiments. II: Regional and subcellular distribution of specific [3H]Harman binding and monoamine oxidase subtypes A and B activity in marmoset and rat, J. Neurochem., 56, 500, 10.1111/j.1471-4159.1991.tb08178.x Moll, 1990, Immunofluorescence cytochemistry on thin frozen sections of human substantia nigra for staining of monoamine oxidase A and monoamine oxidase B: a pilot study, J. Neural Transm., 32, 67 Nomoto, 1986, Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmoset, Eur. J. Pharmac., 121, 123, 10.1016/0014-2999(86)90401-2 Nomoto, 1987, Antiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset, Mov. Disord., 2, 37, 10.1002/mds.870020105 Oreland, 1986, Brain and brain monoamine oxidase in aging and dementia of Alzheimer's type, Prog. Neuro. Psychopharmac. Biol. Pschiatry, 10, 533, 10.1016/0278-5846(86)90023-0 Riederer, 1983, Neurochemical insight into monoamine oxidase inhibitors, with special reference to deprenyl(selegiline), Acta Neurol. Scand., 68, 43, 10.1111/j.1600-0404.1983.tb01516.x Rose, 1989, Treatment with a selective MAOB inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosets, Neuropharmacology, 28, 1211, 10.1016/0028-3908(89)90213-X Waldmeier, 1975, Lack of significance of MAOB for the in vivo deamination of dopamine, Naunyn-Schmiedebergs Arch. Pharmac., 287, R2 Yahr, 1983, Treatment of Parkinson's disease in early and late phases. Use of Pharmacological agents with special reference to deprenyl(selegiline), Acta Nuerol. Scand., 95, 95, 10.1111/j.1600-0404.1983.tb01521.x